import MedQuickFactBar from '../MedQuickFactBar.js'

# GLP-1 receptor agonists

<MedQuickFactBar
a1cText={`0.8-1.2%`}
rountineText={`Weekly / Daily / 2x Daily Injection`}
lowBloodSugarText={`No`}
weightChangeText={`Loss`}
heartBenefitText={`Neutral`}
costText={`High`}
/>

**Injection and oral medication.**

**Dose not cause low blood sugar (hypoglycemia).**

GLP-1 stands for “Glucagon-like peptide-1”

Several different medications in this class

> **Twice Daily**
>
> - Exenatide
>
> **Daily**
>
> - Liraglutide
> - Lixisenatide
>
> **Weekly**
>
> - Dulaglutide
>
> **Weekly injection or Daily oral tablet**
>
> - Semaglutide

**Works by**

- Mimics a hormone that tells the pancreas to release more insulin when we eat or when blood sugars are high
- Slows emptying of the stomach.
- Blocks release of glucagon hormone.
- Decreases appetite

**Efficacy** High

**Pros**

> - Assists with modest weight loss
> - Does not cause hypoglycemia
> - Meal / portion sizes can be reduced without increasing hunger.
> - Heart disease benefit with liraglutide, semaglutide and exenatide extended release

**Cons**

> - Relatively expensive
> - Mostly Injectable (but some options are just once weekly injections)
> - Nausea (especially after a large meal)
> - Headache
> - Diarrhea
> - Rare inflammation of the pancreas (pancreatitis)
